Estrella Immunopharma Inc
NAS:ESLAWHealthcare——At close · Market cap —
| Ratio | FY2021 | FY2022 | FY2024 | FY2023 | FY2024 | FY2025 | Current · undated | Trend | YoY |
|---|---|---|---|---|---|---|---|---|---|
| Return on equity | 162.1% | −14.1% | 94.7% | −171.1% | −6,155.7% | 126.0% | 126.0% | +0.0 pts | |
| Return on assets | −34.2% | −10.0% | −367.0% | −164.2% | −281.7% | −411.2% | −411.2% | +0.0 pts | |
| Return on capital employed | −42.4% | −17.6% | 165.2% | −171.1% | −6,154.5% | 126.0% | — | — | |
| Debt / equity | 0.0× | 0.1× | — | 0.0× | 0.0× | 0.0× | 0.0× | — | |
| Debt / assets | 0.0% | 5.0% | — | 0.0% | 0.0% | 0.0% | — | — | |
| Interest coverage | 0.0× | 0.0× | 0.0× | 0.0× | 0.0× | 0.0× | — | — | |
| Current ratio | 5.2× | 0.0× | 0.3× | 24.6× | 0.5× | 0.1× | 0.1× | +0.0% | |
| Quick ratio | 5.2× | 0.0× | 0.3× | 24.6× | 0.5× | 0.1× | — | — | |
| Cash ratio | 4.3× | 0.0× | 0.3× | 23.1× | 0.3× | 0.1× | 0.1× | +0.0% | |
| Asset turnover | 0.0× | 0.0× | — | 0.0× | 0.0× | 0.0× | — | — | |
| Receivables turnover | — | — | — | 0.0× | — | — | — | — | |
| Dividend payout | 0.0% | 0.0% | — | 0.0% | 0.0% | 0.0% | — | — |
Margins, returns, leverage and liquidityUpdated 31 Dec 2025 ·
ⓘ
Current snapshot ratios have no reporting date and are shown separately from fiscal periods.
